DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
12.39
+0.54 (4.56%)
Sep 14, 2026, 4:00 PM EDT - Market closed
DBV Technologies Employees
As of December 31, 2025, DBV Technologies had 126 total employees, including 125 full-time and 1 part-time employees. The number of employees increased by 16 or 14.55% compared to the previous year.
Employees
126
Change (1Y)
16
Growth (1Y)
14.55%
Revenue / Employee
$39,968
Profits / Employee
-$1,396,405
Market Cap
720.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 126 | 16 | 14.55% | 125 | 1 |
| Dec 31, 2024 | 110 | 5 | 4.76% | 109 | 1 |
| Dec 31, 2023 | 105 | 19 | 22.09% | 104 | 1 |
| Dec 31, 2022 | 86 | -6 | -6.52% | 85 | 1 |
| Dec 31, 2021 | 92 | -50 | -35.21% | 92 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Pharming Group | 407 |
| 4D Molecular Therapeutics | 196 |
| MapLight Therapeutics | 133 |
| Neurogene | 131 |
| Aura Biosciences | 113 |
| Annexon | 92 |
| CytomX Therapeutics | 69 |
DBVT News
- 5 days ago - DBV Technologies Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 10 days ago - DBV Technologies S.A.: DBV Technologies to Participate in Upcoming September Investor Conferences - Finanz Nachrichten
- 10 days ago - DBV Technologies to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 11 days ago - DBV Technologies S.A.: Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026 - Finanz Nachrichten
- 11 days ago - Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026 - GlobeNewsWire
- 6 weeks ago - DBVT Plans $50M ADS Share Issuance Amid Unprofitable Growth Phase - GuruFocus
- 6 weeks ago - DBV Technologies S.A.: DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq - Finanz Nachrichten
- 6 weeks ago - DBV Technologies announces sale of $50M of ADSs through ATM program - TheFly